Valley parents, doctors await COVID-19 vaccine approval for children under 5 years of age
Valley parents, doctors await COVID-19 vaccine approval for children under 5 years of age

Valley parents, doctors await COVID-19 vaccine approval for children under 5 years of age

The Centers for Disease Control and Prevention (CDC) is awaiting trial data for Pfizer’s COVID-19 vaccine for children under five years of age.

Last week, the FDA put the review process on hold when Pfizer asked for more time to collect data.

Valley mother of four Jackie Valencia says her two-month-old baby was having trouble breathing a few weeks ago and she later found out he had COVID-19.

“It was a tough process and I feel like the vaccine was there, it wanted it [have] help him a little more, “said Valencia.” I would [have been] more calm because the vaccine was already in him. “

Brownsville Pediatrician Dr. Asim Zamir says there will eventually be a demand for children under the age of five to get the vaccine.

Zamir says that when the omicron variant appeared, several younger children were affected, resulting in positive cases and hospitalizations.

“A child of two years [or] three-year-old goes into day care, “said Zamir.” So the parents ask, ‘when should we get the vaccine for this age group?’ “

Dr. Jamie Fergie, a pediatric infectious disease specialist at Driscoll Children’s Hospital, is part of a team conducting clinical trials of the COVID-19 vaccine for children.

He says researchers still need to see more data on a possible third dose for children under five because the level of protection for two doses does not match the effectiveness of two doses in older children.


Leave a Reply

Your email address will not be published.